Skip to main content
NCBI home page
The Texas Heart Institute Journal logoLink to The Texas Heart Institute Journal
. 1995;22(2):126–133.

Potential mechanisms of improvement after various treatments for hypertrophic obstructive cardiomyopathy.

R D Leachman 1
PMCID: PMC325231  PMID: 7647595

Abstract

In sum, systolic dysfunction of the ventricle associated with left ventricular outlet obstruction and often with mitral valve regurgitation may be improved by myotomy, myomectomy, mitral valve replacement, and perhaps by the creation of left bundle branch block via DDD right ventricular pacing. Diastolic dysfunction of the ventricle may be improved by prolonging the diastolic filling period, shortening the isovolumic relaxation period with calcium channel blocking drugs, or perhaps by altering the atrioventricular activation time with a DDD pacemaker. The symptoms and complications of associated arrhythmias may be improved by medication, particularly with beta-blockers, which tend to stabilize the atrial rhythm and perhaps the ventricular rhythms. In treating patients with demonstrated ventricular arrhythmias, other antiarrhythmic agents may be helpful. (Table II summarizes the abnormalities, causes, and treatments of hypertrophic obstructive cardiomyopathy.) Epicardial coronary atherosclerosis is not rare in these patients, and arteriographic confirmation may lead to improvement by surgical bypass treatment. Since stroke volume is nearly fixed, cardiac output depends very much on heart rate. For this reason, each patient needs to receive the appropriate dosage of medications to achieve the optimal heart rate for his or her own physiologic state.

Full text

PDF
126

Images in this article

127Image
on p.127
128Image
on p.128
129Image
on p.129

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BROCK R. Functional obstruction of the left ventricle; acquired aortic subvalvar stenosis. Guys Hosp Rep. 1957;106(4):221–238. [PubMed] [Google Scholar]
  2. Bigelow W. G., Trimble A. S., Auger P., Marquis Y., Wigle E. D. The ventriculomyotomy operation for muscular subaortic stenosis. A reappraisal. J Thorac Cardiovasc Surg. 1966 Oct;52(4):514–524. [PubMed] [Google Scholar]
  3. Cokkinos D. V., Krajcer Z., Leachman R. D. Coronary artery disease in hypertrophic cardiomyopathy. Am J Cardiol. 1985 May 1;55(11):1437–1438. doi: 10.1016/0002-9149(85)90526-0. [DOI] [PubMed] [Google Scholar]
  4. Cooley Denton A., Grace R. Randall, Wukasch Don C., Leachman Robert D. REPLACEMENT AND/OR REPAIR OF THE MITRAL VALVE AS TREATMENT OF IDIOPATHIC HYPERTROPHIC SUBAORTIC STENOSIS. Cardiovasc Dis. 1976;3(4):381–393. [PMC free article] [PubMed] [Google Scholar]
  5. Criley J. M., Lewis K. B., White R. I., Jr, Ross R. S. Pressure gradients without obstruction. A new concept of "hypertrophic subaortic stenosis". Circulation. 1965 Dec;32(6):881–887. doi: 10.1161/01.cir.32.6.881. [DOI] [PubMed] [Google Scholar]
  6. EDWARDS J. E. PATHOLOGY OF LEFT VENTRICULAR OUTFLOW TRACT OBSTRUCTION. Circulation. 1965 Apr;31:586–599. doi: 10.1161/01.cir.31.4.586. [DOI] [PubMed] [Google Scholar]
  7. Ellis J. G., Terneny O. J., Winters W. L., Leachman R. D. Critical role of the mitral valve leaflet in hypertrophic subaortic stenosis and amelioration of the disease by mitral valve replacement. Chest. 1971 Apr;59(4):378–382. doi: 10.1378/chest.59.4.378. [DOI] [PubMed] [Google Scholar]
  8. Fananapazir L., Cannon R. O., 3rd, Tripodi D., Panza J. A. Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy. Circulation. 1992 Jun;85(6):2149–2161. doi: 10.1161/01.cir.85.6.2149. [DOI] [PubMed] [Google Scholar]
  9. Fighali S., Krajcer Z., Leachman R. D. Septal myomectomy and mitral valve replacement for idiopathic hypertrophic subaortic stenosis: short- and long-term follow-up. J Am Coll Cardiol. 1984 May;3(5):1127–1134. doi: 10.1016/s0735-1097(84)80169-2. [DOI] [PubMed] [Google Scholar]
  10. Frank M. J., Abdulla A. M., Canedo M. I., Saylors R. E. Long-term medical management of hypertrophic obstructive cardiomyopathy. Am J Cardiol. 1978 Dec;42(6):993–1001. doi: 10.1016/0002-9149(78)90687-2. [DOI] [PubMed] [Google Scholar]
  11. Frank S., Braunwald E. Idiopathic hypertrophic subaortic stenosis. Clinical analysis of 126 patients with emphasis on the natural history. Circulation. 1968 May;37(5):759–788. doi: 10.1161/01.cir.37.5.759. [DOI] [PubMed] [Google Scholar]
  12. GOODWIN J. F., HOLLMAN A., CLELAND W. P., TEARE D. Obstructive cardiomyopathy simulating aortic stenosis. Br Heart J. 1960 Jun;22:403–414. doi: 10.1136/hrt.22.3.403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Grines C. L., Bashore T. M., Boudoulas H., Olson S., Shafer P., Wooley C. F. Functional abnormalities in isolated left bundle branch block. The effect of interventricular asynchrony. Circulation. 1989 Apr;79(4):845–853. doi: 10.1161/01.cir.79.4.845. [DOI] [PubMed] [Google Scholar]
  14. Hanrath P., Mathey D., Montz R., Thiel U., Vorbringer H., Kupper W., Schneider C., Bleifeld W. Myocardial thallium 201 imaging in hypertrophic obstructive cardiomyopathy. Eur Heart J. 1981 Jun;2(3):177–185. doi: 10.1093/oxfordjournals.eurheartj.a061192. [DOI] [PubMed] [Google Scholar]
  15. Hultgren H. N., Craige E., Fujii J., Nakamura T., Bilisoly J. Left bundle branch block and mechanical events of the cardiac cycle. Am J Cardiol. 1983 Oct 1;52(7):755–762. doi: 10.1016/0002-9149(83)90411-3. [DOI] [PubMed] [Google Scholar]
  16. Jeanrenaud X., Goy J. J., Kappenberger L. Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy. Lancet. 1992 May 30;339(8805):1318–1323. doi: 10.1016/0140-6736(92)91961-7. [DOI] [PubMed] [Google Scholar]
  17. Leachman R. D., Krajcer Z., Azic T., Cooley D. A. Mitral valve replacement in hypertrophic cardiomyopathy: ten-year follow-up in 54 patients. Am J Cardiol. 1987 Dec 1;60(16):1416–1418. doi: 10.1016/0002-9149(87)90637-0. [DOI] [PubMed] [Google Scholar]
  18. Maron B. J., Epstein S. E., Roberts W. C. Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries. Am J Cardiol. 1979 Jun;43(6):1086–1102. doi: 10.1016/0002-9149(79)90139-5. [DOI] [PubMed] [Google Scholar]
  19. Maron B. J., Lipson L. C., Roberts W. C., Savage D. D., Epstein S. E. "Malignant" hypertrophic cardiomyopathy: identification of a subgroup of families with unusually frequent premature death. Am J Cardiol. 1978 Jun;41(7):1133–1140. doi: 10.1016/0002-9149(78)90870-6. [DOI] [PubMed] [Google Scholar]
  20. Maron B. J., Roberts W. C., Epstein S. E. Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients. Circulation. 1982 Jun;65(7):1388–1394. doi: 10.1161/01.cir.65.7.1388. [DOI] [PubMed] [Google Scholar]
  21. Maron B. J., Roberts W. C., McAllister H. A., Rosing D. R., Epstein S. E. Sudden death in young athletes. Circulation. 1980 Aug;62(2):218–229. doi: 10.1161/01.cir.62.2.218. [DOI] [PubMed] [Google Scholar]
  22. Maron B. J., Savage D. D., Wolfson J. K., Epstein S. E. Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study. Am J Cardiol. 1981 Aug;48(2):252–257. doi: 10.1016/0002-9149(81)90604-4. [DOI] [PubMed] [Google Scholar]
  23. Maron B. J., Wolfson J. K., Epstein S. E., Roberts W. C. Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol. 1986 Sep;8(3):545–557. doi: 10.1016/s0735-1097(86)80181-4. [DOI] [PubMed] [Google Scholar]
  24. McDonald K., McWilliams E., O'Keeffe B., Maurer B. Functional assessment of patients treated with permanent dual chamber pacing as a primary treatment for hypertrophic cardiomyopathy. Eur Heart J. 1988 Aug;9(8):893–898. doi: 10.1093/oxfordjournals.eurheartj.a062584. [DOI] [PubMed] [Google Scholar]
  25. McKenna W. J., England D., Doi Y. L., Deanfield J. E., Oakley C., Goodwin J. F. Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis. Br Heart J. 1981 Aug;46(2):168–172. doi: 10.1136/hrt.46.2.168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. McKenna W. J., Harris L., Perez G., Krikler D. M., Oakley C., Goodwin J. F. Arrhythmia in hypertrophic cardiomyopathy. II: Comparison of amiodarone and verapamil in treatment. Br Heart J. 1981 Aug;46(2):173–178. doi: 10.1136/hrt.46.2.173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. McKenna W., Deanfield J., Faruqui A., England D., Oakley C., Goodwin J. Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features. Am J Cardiol. 1981 Mar;47(3):532–538. doi: 10.1016/0002-9149(81)90535-x. [DOI] [PubMed] [Google Scholar]
  28. Murgo J. P., Alter B. R., Dorethy J. F., Altobelli S. A., McGranahan G. M., Jr Dynamics of left ventricular ejection in obstructive and nonobstructive hypertrophic cardiomyopathy. J Clin Invest. 1980 Dec;66(6):1369–1382. doi: 10.1172/JCI109990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Pridie R. B., Oakley C. Mitral valve movement in hypertrophic obstructive cardiomyopathy. Br Heart J. 1969 May;31(3):390–390. [PubMed] [Google Scholar]
  30. SELLERS R. D., LILLEHEI C. W., EDWARDS J. E. SUBAORTIC STENOSIS CAUSED BY ANOMALIES OF THE ATRIOVENTRICULAR VALVES. J Thorac Cardiovasc Surg. 1964 Aug;48:289–302. [PubMed] [Google Scholar]
  31. SPODICK D. H., LITTMANN D. Idiopathic myocardial hypertrophy. Am J Cardiol. 1958 May;1(5):610–623. doi: 10.1016/0002-9149(58)90145-0. [DOI] [PubMed] [Google Scholar]
  32. Shah P. M., Gramiak R., Kramer D. H. Ultrasound localization of left ventricular outflow obstruction in hypertrophic obstructive cardiomyopathy. Circulation. 1969 Jul;40(1):3–11. doi: 10.1161/01.cir.40.1.3. [DOI] [PubMed] [Google Scholar]
  33. Spirito P., Chiarella F., Carratino L., Berisso M. Z., Bellotti P., Vecchio C. Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population. N Engl J Med. 1989 Mar 23;320(12):749–755. doi: 10.1056/NEJM198903233201201. [DOI] [PubMed] [Google Scholar]
  34. Stenson R. E., Flamm M. D., Jr, Harrison D. C., Hancock E. W. Hypertrophic subaortic stenosis. Clinical and hemodynamic effects of long-term propranolol therapy. Am J Cardiol. 1973 Jun;31(6):763–773. doi: 10.1016/0002-9149(73)90012-x. [DOI] [PubMed] [Google Scholar]
  35. Stewart J. T., McKenna W. J. Management of arrhythmias in hypertrophic cardiomyopathy. Cardiovasc Drugs Ther. 1994 Feb;8(1):95–99. doi: 10.1007/BF00877095. [DOI] [PubMed] [Google Scholar]
  36. TEARE D. Asymmetrical hypertrophy of the heart in young adults. Br Heart J. 1958 Jan;20(1):1–8. doi: 10.1136/hrt.20.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. TRIMBLE A. S., BIGELOW W. G., WIGLE E. D., CHRYSOHOU A. SIMPLE AND EFFECTIVE SURGICAL APPROACH TO MUSCULAR SUBAORTIC STENOSIS. Circulation. 1964 Apr;29:SUPPL–SUPPL:129. [PubMed] [Google Scholar]
  38. WIGLE E. D., CHRYSOHOU A., BIGELOW W. G. Results of ventriculomyotomy in muscular subaortic stenosis. Am J Cardiol. 1963 May;11:572–586. doi: 10.1016/0002-9149(63)90076-6. [DOI] [PubMed] [Google Scholar]
  39. Weiss M. B., Ellis K., Sciacca R. R., Johnson L. L., Schmidt D. H., Cannon P. J. Myocardial blood flow in congestive and hypertrophic cardiomyopathy: relationship to peak wall stress and mean velocity of circumferential fiber shortening. Circulation. 1976 Sep;54(3):484–494. doi: 10.1161/01.cir.54.3.484. [DOI] [PubMed] [Google Scholar]

Articles from Texas Heart Institute Journal are provided here courtesy of Texas Heart Institute

RESOURCES